Bristol Myers Squibb's Revenue in the fiscal year 2025 $ 48,194.00 millions
Bristol Myers Squibb's Revenue in the fiscal year 2024 $ 48,300.00 millions
Bristol Myers Squibb's Revenue in the fiscal year 2023 $ 45,006.00 millions
Bristol Myers Squibb's Revenue in the fiscal year 2022 $ 46,159.00 millions
Bristol Myers Squibb's Revenue in the fiscal year 2021 $ 46,385.00 millions
BMY Revenue third quarter 2026 Y/Y Growth Comment
Bristol myers Squibb Company achieved in the third quarter 2026, above Company average Revenue improvement of 6.93% year on year, to $ 13,069.00 millions.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 114 other companies have achieved higher Revenue growth. While Bristol Myers Squibb Company' s Revenue increase of 6.93% ranks overall at the positon no. 2110 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Bristol Myers Squibb's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
35.7 %
1.35 %
-15.91 %
(Mar 31 2020)
BMY's III. Quarter Q/Q Revenue Comment
Bristol myers Squibb Company achieved in the III. Quarter 2026 below company average Revenue growth of 0.74% quarter on quarter, to $ 13,069.00 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.38% in the III. Quarter a year ago.
Within Major Pharmaceutical Preparations industry 82 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 1695.
Bristol myers Squibb Company achieved in the III. Quarter 2026 below company average Revenue growth of 0.74% quarter on quarter, to $ 13,069.00 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.38% in the III. Quarter a year ago.
Within Major Pharmaceutical Preparations industry 82 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 1695.
Bristol Myers Squibb's 12 Months Revenue Growth Year on Year
Although Bristol Myers Squibb's Annual Revenue growth year on year were below company's average 5.32% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.16% year on year, from 3.11% in Jun 30 2026.
In the Healthcare sector 359 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2483, from total ranking in previous quarter at 3061.
Although Bristol Myers Squibb's Annual Revenue growth year on year were below company's average 5.32% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.16% year on year, from 3.11% in Jun 30 2026.
In the Healthcare sector 359 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2483, from total ranking in previous quarter at 3061.
About Bristol Myers Squibb Revenue Growth Rates (BMY), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.85%